This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: The United States Government as Represented by the Department of Veterans Affairs, University of South Florida, Office of General Counsel—psg IV (024). Active years: 2019-2020.
Company Filing History:
2 out of 955 
2 out of 1,985 
1 out of 1 Years Active: 2019-2020
Title: Carmelina Gemma: Innovator in Neuroinflammatory and Neurodegenerative Disease Treatments
Introduction
Carmelina Gemma is a prominent inventor based in Bellevue, WA (US). She has made significant contributions to the field of neuroinflammation and neurodegeneration through her innovative research and patented inventions. With a total of 2 patents, her work focuses on developing methods for treating various neurological disorders.
Latest Patents
Carmelina Gemma's latest patents include groundbreaking methods for the treatment of neuroinflammatory and neurodegenerative diseases. One notable invention is the recombinant adeno-associated virus-mediated expression of fractalkine for treatment of these conditions. This invention pertains to the use of fractalkine (FKN, CX3CL1) and its receptor CX3CR1, providing a method for treating neuroinflammation and neurodegeneration. The invention specifically addresses conditions such as Parkinson's disease, Alzheimer's disease, epilepsy, aging, and traumatic brain injury. Another significant patent involves methods of treating epilepsy using neural stem cells that express specific markers, offering new avenues for diagnosing and treating epilepsy-related disorders.
Career Highlights
Carmelina has worked with esteemed institutions, including the University of South Florida and the United States Government as represented by the Department of Veterans Affairs. Her career reflects a commitment to advancing medical science and improving patient outcomes through innovative treatments.
Collaborations
Throughout her career, Carmelina has collaborated with notable colleagues, including Paula Cole Bickford and Kevin Ron Nash. These partnerships have further enriched her research and contributed to the development of her patented inventions.
Conclusion
Carmelina Gemma stands out as a dedicated inventor in the field of neuroinflammatory and neurodegenerative disease treatments. Her innovative patents and collaborations highlight her commitment to advancing medical science and improving the lives of those affected by neurological disorders.